AVERSA, Franco
 Distribuzione geografica
Continente #
NA - Nord America 2.757
EU - Europa 1.982
AS - Asia 1.906
SA - Sud America 290
AF - Africa 40
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.979
Nazione #
US - Stati Uniti d'America 2.697
SG - Singapore 910
IE - Irlanda 350
UA - Ucraina 312
CN - Cina 276
SE - Svezia 253
IT - Italia 235
RU - Federazione Russa 234
BR - Brasile 223
HK - Hong Kong 213
VN - Vietnam 180
FI - Finlandia 143
DE - Germania 133
FR - Francia 109
KR - Corea 92
GB - Regno Unito 80
IN - India 54
TR - Turchia 34
CA - Canada 33
BD - Bangladesh 32
AR - Argentina 28
IQ - Iraq 20
NL - Olanda 20
PL - Polonia 20
JP - Giappone 19
BE - Belgio 15
MX - Messico 15
AT - Austria 14
CZ - Repubblica Ceca 14
ZA - Sudafrica 14
PK - Pakistan 12
UZ - Uzbekistan 12
CH - Svizzera 11
EC - Ecuador 11
CO - Colombia 7
ES - Italia 7
SA - Arabia Saudita 7
VE - Venezuela 7
GR - Grecia 6
KE - Kenya 6
MA - Marocco 6
PH - Filippine 6
RO - Romania 6
BO - Bolivia 5
JO - Giordania 5
MY - Malesia 5
CL - Cile 4
EG - Egitto 4
IL - Israele 4
LB - Libano 4
PY - Paraguay 4
AL - Albania 3
ID - Indonesia 3
NP - Nepal 3
PS - Palestinian Territory 3
TN - Tunisia 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
SI - Slovenia 1
TW - Taiwan 1
UG - Uganda 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 6.979
Città #
Singapore 671
Chandler 393
Dublin 348
San Jose 231
Hong Kong 213
San Mateo 200
Ashburn 173
Jacksonville 170
Boardman 136
Santa Clara 103
Seoul 86
Moscow 85
Perugia 82
Dong Ket 77
Beijing 74
Medford 69
Princeton 68
Lauterbourg 66
Ann Arbor 58
Andover 55
Munich 51
Altamura 50
New York 49
Helsinki 46
Wilmington 44
Lawrence 42
Los Angeles 39
Piscataway 36
Ho Chi Minh City 34
Turku 32
Hanoi 26
The Dalles 26
São Paulo 25
Des Moines 22
Houston 22
Saint Petersburg 21
Tokyo 19
Brooklyn 17
Woodbridge 17
Norwalk 16
Orem 16
Shanghai 15
Johannesburg 14
Montreal 14
Brussels 13
Izmir 13
San Francisco 13
Amsterdam 12
Chennai 12
Stockholm 12
Warsaw 12
Auburn Hills 11
Dallas 11
Phoenix 11
San Paolo di Civitate 11
Frankfurt am Main 10
London 10
Tashkent 10
Vienna 10
Brno 9
Chicago 9
Seattle 9
Atlanta 8
Nuremberg 8
Rio de Janeiro 8
Baghdad 7
Dearborn 7
Denver 7
Espoo 7
New Delhi 7
Quito 7
Bologna 6
Council Bluffs 6
Curitiba 6
Falls Church 6
Mumbai 6
Ottawa 6
Renton 6
San Diego 6
Toronto 6
Barnet 5
Boston 5
Brasília 5
Columbus 5
Dhaka 5
Guangzhou 5
Istanbul 5
Lahore 5
Manchester 5
Nairobi 5
Poplar 5
Rome 5
Tianjin 5
Amman 4
Ankara 4
Caracas 4
Charlotte 4
Falkenstein 4
Hanover 4
Hefei 4
Totale 4.462
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 182
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 153
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 140
Graft engineering for allogeneic haploidentical stem cell transplantation 134
Acute lymphoblastic leukaemia in Noonan syndrome 129
Fourth international workshop on haploidentical transplants, Naples, Italy 125
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils 124
"Designed" grafts for HLA-haploidentical stem cell transplantation. 123
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 121
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 121
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 120
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 119
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 118
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 117
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 116
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 116
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 115
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 113
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 113
Toxoplasma gondii infection in bone marrow transplant recipients: the polymerase chain reaction-blood sample combination in diagnosis and early detection. 111
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 109
Competing risks analysis using R: an easy guide for clinicians 108
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. 107
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 105
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 104
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 101
Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation 100
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 97
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 96
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 96
Stem cell mobilization in normal donors. 95
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 93
Haploidentical stem cell transplantation for acute leukemia 92
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 92
Mismatched hematopoietic stem cell transplantation in secondary leukemia 91
Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome 91
PML is required for telomere stability in non-neoplastic human cells 91
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 90
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 88
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL) 87
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 86
New mechanism of lymphoma-induced bone marrow aplasia 86
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 85
Haploidentical transplantation and natural killer cell recognition of missing self. 83
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 83
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. 82
Improved Outcome With T-Cell–Depleted Bone Marrow Transplantation for Acute Leukemia 82
Outcomes of unrelated cord blood and haploidentical stem cell transplantation in adults with acute leukaemia. 81
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 81
Infezioni da Cytomegalovirus nel paziente immunodepresso. 81
Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation 80
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 78
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 77
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 77
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 76
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 76
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 74
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 73
Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use 73
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 72
Natural killer cells as a therapeutic tool in mismatched transplantation 72
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 71
The Evolution of T Cell Depleted Haploidentical Transplantation 70
Regression Modeling of Competing Risk Using R: An In Depth Guide for Clinicians 69
The haploidentical option for high-risk haematological malignancies. 65
Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases 63
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 63
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. 63
null 63
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 56
The role of bronchoalveolar lavage (BAL) in immunocompromised haematological patients. 56
Hairy cell leukaemia mimicking multiple myeloma 55
Haploidentical stem cell transplantation in leukemia 54
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 53
T-cell–depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT) 52
null 46
Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity. 44
Hematopoietic Cell Transplantation from Human Leukocyte Antigen Partially Matched Related Donors 44
null 36
null 11
Totale 7.135
Categoria #
all - tutte 30.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 31 58 90
2021/2022650 13 165 25 47 19 4 9 190 6 13 73 86
2022/20231.202 81 197 9 102 129 118 2 66 443 11 34 10
2023/2024491 26 60 25 8 8 6 108 12 61 18 73 86
2024/20251.108 26 119 67 59 123 44 69 60 192 58 193 98
2025/20262.398 164 151 101 320 380 251 445 125 262 199 0 0
Totale 7.135